STRF combines Bitcoin-linked upside and fixed-income stability in a structurally senior preferred security that remains mispriced. Read why STRF is an intriguing opportunity.
Associated Banc-Corp demonstrates strong fundamentals, including a growing CET1 ratio, stable outlook, and consistent dividend history. Read why ASBA is a Buy.
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
Long-term Treasury bonds show strong historical returns, but recent short-term risks arise. Learn why balanced portfolios still value them. Click for more.
Discover why PIMCO's PTY stands out as a 'Strong Buy' among high-yield funds, while PDO is a buy. Click here to read the most recent analysis of these PIMCO CEFs.